| Cat.#: 28018 |
| Product Name: Anti-PDL1 (Atezolizumab) Monoclonal Antibody |
| Synonyms: PD-L1;CD274;B7-H1;PDCD1L1;PDCD1LG1 |
| Description: Anti-PDL1 (atezolizumab ) Monoclonal Antibody |
| Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
| Applications: ELISA; Flow Cyt |
| Recommended Dilutions: ELISA 1:5000-10000; Flow Cyt 1:100 |
| Host Species: Humanized |
| Isotype: IgG1 |
| Purification: Purified from cell culture supernatant by affinity chromatography |
| Species Reactivity: Human PDL1 |
| Constituents: Lyophilized from sterile PBS, pH 7.4. 5 % – 8% trehalose is added as protectants before lyophilization. |
| Storage & Shipping: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). |
Figure 1. ELISA plate pre-coated by 2 µg/ml (100 µl/well) Human PDL1, mFc-His tagged protein 11151 can bind Anti-PDL1 Neutralizing antibody in a linear range of 0.24-7.81 ng/ml. | 
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human PDL1 (A) were surface stained with anti-PDL1 neutralizing antibody 1µg/ml (atezolizumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody. |
|
